Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

• Status: Completed
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: VA Office of Research and Development
• Treatments: Armodafinil; Methamphetamine; Modafinil

Criteria

Inclusion Criteria:

• Must be between the ages of 18 and 65

• Methamphetamine dependent as defined by DSM-IV criteria

• Must be in good general heath with a history of methamphetamine use at screening

• Must be able to provide written informed consent

• If female and of child bearing potential, must agree to use birth control.

Exclusion Criteria:

• Please contact site for more information